Esposito Pamela sold KYMR
January 20, 2026 · Form 4 insider transaction
Esposito Pamela sold 200 shares of Kymera Therapeutics, Inc. at $68.52 per share, a transaction worth $13.7K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
200
Price
$68.52
Total value
$13.7K
InsiderEsposito Pamela
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJanuary 20, 2026
Filing dateJanuary 20, 2026
Shares owned after0
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These transactions were effected pursuant to a Rule 10b5-1 trading plan dated September 17, 2025 adopted by the reporting person.